H. autoimmune diseases and aplastic anemia

The severity of acquired aplastic anemia (AA) and long-term prognosis: lessons from current results of immunosuppressive treatment (IST)

Alexander D. Kulagin^1,2, Igor A. Lisukov^1,2, Vyacheslav I. Borisov², Irina V. Kruchkova², Vera V. Sergeevicheva², Svetlana A. Sizikova², Andrey V. Gilevich², Vladimir S. Kozhevnikov², Vladimir A. Kozlov²

Immunoablation followed by autologous stem cell transplantation in refractory autoimmune diseases: clinical outcomes and immune reconstitution

Igor A. Lisukov^1,2, Vera V. Sergeevicheva², Svetlana A. Sizikova², Alexander D. Kulagin^1,2, Irina V. Kruchkova², Andrey V. Gilevich², Alexey E. Sizikov², Lyudmila P. Konenkova², Elena R. Chernykh², Vladimir S. Kozhevnikov², Alexander A. Demin¹, Vladimir A. Kozlov²

Outcomes of hematopoietic cell transplantation (SCT) and combined immunosupression (IST) patients with severe aplastic anemia (SAA) admitted with life-threatening infections

Galina A. Novichkova, Mikhail A. Maschan, Lili A. Khachatrian, Dina D. Baidildina, Olga V. Goronkova, Galina G. Solopova, Elena V. Skorobogatova, Irina P. Shipitsina, Alexey A. Maschan

Mesenchymal stem cell transplantation in patents with amyotrophic lateral sclerosis and multiple sclerosis

Miroslav M. Odinak¹, Gennadiy N. Bisaga¹, Andrey V. Novitsky², Vadim V. Tirenko², Dmitriy N. Sculyabin¹, Dmitriy G. Polyntsev³, Petr V. Krugliakov³, Anna N. Bilibina³, A. Kolchenko³

Alternative method for treating acquired aplastic anemia

Yuri I. Yugov, Nina A. Fedorovskaya, Alexander S. Luchinin

H. Autoimmune diseases and aplastic anemia